Clark Capital Management Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Clark Capital Management Group's BSX Position: Q2 2026 in Review
Clark Capital Management Group reduced its Boston Scientific (BSX) stake by 92% in Q2 2026, selling an estimated $5.91M and leaving 9,532 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #425.
Clark Capital Management Group first reported a position in BSX in Q2 2013 and has held it in 15 quarters since. The position peaked at $7.43M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Clark Capital Management Group held 9,532 shares of Boston Scientific worth $407K as of Q2 2026.
- Clark Capital Management Group sold 108,832 Boston Scientific shares in Q2 2026, an estimated $5.91M.
- Boston Scientific made up ﹤0.01% of Clark Capital Management Group's portfolio in Q2 2026, its #425 holding.
- Clark Capital Management Group first reported a position in Boston Scientific in Q2 2013 and has held it in 15 quarters since.
- Clark Capital Management Group's Boston Scientific position peaked at $7.43M in Q1 2026.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Clark Capital Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.